These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 702322)

  • 41. Hepatic injury in patients who have received iproniazid.
    POPPER H
    Ann N Y Acad Sci; 1959 Sep; 80():928-38. PubMed ID: 14434190
    [No Abstract]   [Full Text] [Related]  

  • 42. [Serial hepatic study of patients treated with iproniazid].
    KATZ R; KLINGER J; SILVA L; RODRIGUEZ J; DUCCI H
    Rev Med Chil; 1959 Jun; 87():421-9. PubMed ID: 14404814
    [No Abstract]   [Full Text] [Related]  

  • 43. Metabolic Fate of β-Aspartyl-(14)C-glycine in Normal Young Rats.
    Tanaka H; Noutomi K; Akiba M; Nishi H
    Biosci Biotechnol Biochem; 1992 Jan; 56(4):644-7. PubMed ID: 27280663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The 5-hydroxytryptamine content of mouse brain and whole mice after treatment with some drugs affecting the central nervous system.
    Bartlet AL
    Br J Pharmacol Chemother; 1960 Mar; 15(1):140-6. PubMed ID: 19108131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanism of the neurotoxic and hepatotoxic effects of carbon disulfide.
    Dalvi RR
    Drug Metabol Drug Interact; 1988; 6(3-4):275-84. PubMed ID: 3078292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Demonstration of 3,4-dihydroxy(14C)benzoic acid and (14C)vanillic acid after administration of (14C)noradrenaline in the rat.
    Peskar B; Hellmann G; Hertting G
    J Pharm Pharmacol; 1971 Apr; 23(4):270-5. PubMed ID: 4396904
    [No Abstract]   [Full Text] [Related]  

  • 47. The metabolism of iproniazid.
    KOECHLIN B; ILIEV V
    Ann N Y Acad Sci; 1959 Sep; 80():864-72. PubMed ID: 14410386
    [No Abstract]   [Full Text] [Related]  

  • 48. Hepatic and renal damage with azotemia associated with iproniazid administration.
    SPELLBERG MA; FRANKEL JJ
    Am J Gastroenterol; 1962 Jan; 37():64-9. PubMed ID: 13915635
    [No Abstract]   [Full Text] [Related]  

  • 49. Hepatic necrosis associated with iproniazid administration. Epidemiological observations in a fatal case.
    JOSKE RA; WALTERS MN
    Gastroenterologia; 1962; 98():273-80. PubMed ID: 13964970
    [No Abstract]   [Full Text] [Related]  

  • 50. [On the problem of a possible liver toxicity of iproniazid].
    LAEUPPI E; SCHAERER K; STUDER A
    Psychiatr Neurol (Basel); 1960 Jul; 140():241-5. PubMed ID: 13758162
    [No Abstract]   [Full Text] [Related]  

  • 51. [Liver function tests under iproniazid treatment].
    KRISTJANSEN P; MYSCHETZKY A; HASLUND J
    Ugeskr Laeger; 1959 Sep; 121():1446-8. PubMed ID: 14412051
    [No Abstract]   [Full Text] [Related]  

  • 52. Liver-function tests in patients receiving iproniazid.
    ZETZEL L; KAPLAN H; DUSSIK KT
    Am J Dig Dis; 1959 Dec; 4():1027-33. PubMed ID: 13847328
    [No Abstract]   [Full Text] [Related]  

  • 53. Methane formation in vivo from N-isopropyl alpha(2-methylhydrazino)-p-toluamide hydrochloride, a tumor-inhibiting methylhydrazine derivative.
    Dost FN; Reed DJ
    Biochem Pharmacol; 1967 Sep; 16(9):1741-6. PubMed ID: 6053216
    [No Abstract]   [Full Text] [Related]  

  • 54. [Iproniazid poisoning. A fatal case with liver and kidney damage].
    VISFELDT J
    Ugeskr Laeger; 1961 Dec; 123():1727-8. PubMed ID: 13926229
    [No Abstract]   [Full Text] [Related]  

  • 55. [Icterus caused by iproniazid].
    URBINATI G; GIULIANI A
    Epatologia; 1960; 6():493-511. PubMed ID: 13779293
    [No Abstract]   [Full Text] [Related]  

  • 56. [Iproniazid as the cause of hepatocellular jaundice].
    HANGAARD G
    Nord Med; 1962 Aug; 68():1071-3. PubMed ID: 13904334
    [No Abstract]   [Full Text] [Related]  

  • 57. Jaundice following iproniazid administration with recovery; serial biochemical and histological observations of two patients.
    BRALOW SP; SHAY H
    Am J Dig Dis; 1959 Dec; 4():1014-26. PubMed ID: 13803808
    [No Abstract]   [Full Text] [Related]  

  • 58. Cardiac toxicity of iproniazid (marsilid): report of myocardial injury in a patient receiving levarterenol.
    MOND E; MACK I
    Am Heart J; 1960 Jan; 59():134-9. PubMed ID: 14423518
    [No Abstract]   [Full Text] [Related]  

  • 59. Iproniazid jaundice.
    MILNER LR
    Am J Gastroenterol; 1961 May; 35():456-63. PubMed ID: 13770966
    [No Abstract]   [Full Text] [Related]  

  • 60. [Icterus originating under iproniazid treatment: report on 3 cases].
    MADSEN S; REITER PJ; JENSEN E
    Ugeskr Laeger; 1959 Sep; 121():1448-51. PubMed ID: 14419701
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.